Publicaciones en colaboración con investigadores/as de Universitat Autònoma de Barcelona (30)

2024

  1. Compassionate use of esketamine intranasal in patients with severe major depressive disorder resistant to the treatment

    Journal of Psychopharmacology

2023

  1. A systematic review of digital interventions for smoking cessation in patients with serious mental illness

    Psychological Medicine, Vol. 53, Núm. 11, pp. 4856-4868

  2. Guía internacional para una dosificación más segura de la clozapina en adultos mediante el uso de 6 titulaciones personalizadas de dosis basados en la etnicidad, la proteína C reactiva y los niveles de clozapina

    Psiquiatría biológica: Publicación oficial de la Sociedad Española de Psiquiatría Biológica, Vol. 30, Núm. 3

  3. Meta-analysis of the effects of adjuvant drugs in co-occurring bipolar and substance use disorder

    Revista de Psiquiatria y Salud Mental

2022

  1. 2022: IS IT TIME TO OPEN THE DOORS IN THE ACUTE PSYCHIATRIC HOSPITALISATION?

    Actas Espanolas de Psiquiatria

  2. Awareness of illness moderates self-assessment of psychotic symptoms

    Australian and New Zealand Journal of Psychiatry, Vol. 56, Núm. 10, pp. 1287-1294

  3. Erratum: Correction: An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels (Pharmacopsychiatry (2022) 55 2 (73-86))

    Pharmacopsychiatry

  4. Evaluating maintenance electroconvulsive therapy in Bipolar Disorders: 3-year mirror-image study

    Journal of Affective Disorders, Vol. 298, pp. 58-64

  5. Toward Understanding of Suicidality in a Spanish Clinical Population: Validation of the European Spanish Version of the Interpersonal Needs Questionnaire

    Psychopathology, Vol. 55, Núm. 1, pp. 16-27

2021

  1. Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings

    Molecular Psychiatry, Vol. 26, Núm. 8, pp. 4529-4543

  2. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

    Nature communications, Vol. 12, Núm. 1, pp. 3417

  3. Early intervention services, patterns of prescription and rates of discontinuation of antipsychotic treatment in first-episode psychosis

    Early Intervention in Psychiatry, Vol. 15, Núm. 6, pp. 1584-1594

  4. Identifying clinical clusters with distinct trajectories in first-episode psychosis through an unsupervised machine learning technique

    European Neuropsychopharmacology, Vol. 47, pp. 112-129

  5. Mental disorders, psychopharmacological treatments, and mortality in 2150 COVID-19 Spanish inpatients

    Acta Psychiatrica Scandinavica, Vol. 143, Núm. 6, pp. 526-534

  6. Pre-training inter-rater reliability of clinical instruments in an international psychosis research project

    Schizophrenia Research

  7. Premorbid Characteristics as Predictors of Early Onset Versus Adult Onset in Patients with a First Episode of Psychosis

    Journal of Clinical Psychiatry, Vol. 82, Núm. 6

  8. Women in Forensic Mental Health Services: Lived Experiences and Meanings Attributed to Activities in Rehabilitation Programs. Study Protocol

    International Journal of Qualitative Methods, Vol. 20

2019

  1. CIBERSAM: Ten years of collaborative translational research in mental disorders

    Revista de Psiquiatria y Salud Mental, Vol. 12, Núm. 1, pp. 1-8

  2. Food craving and consumption evolution in patients starting treatment with clozapine

    Psychopharmacology, Vol. 236, Núm. 11, pp. 3317-3327

2017

  1. Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: Results of a randomized, double-blind clinical trial

    BMC Psychiatry, Vol. 17, Núm. 1